Patent details

Basic Information

Publication number:

EP3413923

PCT Application Number:

EP2017052988

Type:

European Patent Granted for LU

Legal Status:

In force

Application number:

EP177042637

PCT Publication Number:

WO2017137553

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

PYRROLOBENZODIAZEPINE CONJUGATES

French Title of Invention:

CONJUGUÉS DE PYRROLOBENZODIAZÉPINE

German Title of Invention:

PYRROLOBENZODIAZEPINKONJUGATE

SPC Number:

Dates

Filing date:

10/02/2017

Grant date:

08/04/2020

EP Publication Date:

19/12/2018

PCT Publication Date:

17/08/2017

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

08/04/2020

EP B1 Publication Date:

08/04/2020

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

10/02/2037

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

01/04/2020

 

 

Name:

Medimmune Limited

Address:

Milstein Building Granta Park, Cambridge, Cambridgeshire CB21 6GH, United Kingdom (GB)

Inventor

1

Name:

MASTERSON, Luke

Address:

United Kingdom (GB)

2

Name:

HOWARD, Philip Wilson

Address:

United Kingdom (GB)

3

Name:

DUNNY, Elizabeth

Address:

United Kingdom (GB)

Priority

Priority Number:

201602356

Priority Date:

10/02/2016

Priority Country:

United Kingdom (GB)

Classification

IPC classification:

A61P 35/00; A61K 47/68;

Publication

European Patent Bulletin

Issue number:

202015

Publication date:

08/04/2020

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

31/08/2021

Annual Fee Number:

5

Annual Fee Amount:

52 Euro

Penalty Fee Amount:

20 Euro

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages